NanoString Technologies ROA 2024

Ką veikia NanoString Technologies?

NanoString Technologies Inc. is a company based in Seattle, USA, founded in 2003. The company's main focus is the development and commercialization of diagnostic tests and platforms for genomics and proteomics. Business Model: NanoString Technologies offers innovative solutions for gene and protein analysis. The company's products are used worldwide by researchers, clinics, and pharmaceutical companies to better understand diseases, make more precise diagnoses, and develop therapies. The company targets both academic research and industry. Divisions and Products: In the genomics field, NanoString Technologies offers the nCounter® platform. This technology allows for the measurement of the expression of over 800 genes simultaneously directly in tissue samples. mRNA is converted to cDNA and then detected using barcodes. The method is highly specific and sensitive, which is particularly advantageous in cancer research. For protein analysis, NanoString Technologies offers the GeoMx® Digital Spatial Profiling (DSP) platform. This allows for the direct localization and quantification of proteins in tissue sections. The method is high-resolution and enables the investigation of protein expressions within a cell community. In addition to these platforms, the company also offers various panels that can measure a specific amount of genes or proteins at once. These include, for example, the PanCancer Immune Profiling Panel, which provides information about the immune response in tumors, or the nCounter® Neuropathology Panel, which is used for the diagnosis of neurological disorders. History: NanoString Technologies was founded in 2003 by brothers Krassen and Dimitris Draganov. They developed the nCounter® platform, which was officially launched in 2008. In 2010, the company received a $20 million investment, which allowed for the expansion of the product range. Further funding rounds followed and the successful IPO took place in June 2013. Since then, the company has focused on expanding its product portfolio and improving its technologies. Conclusion: NanoString Technologies has quickly established itself as a major provider in the genomics and proteomics field. The nCounter® and GeoMx® platforms have proven to be highly specific and sensitive analysis tools and are used worldwide in research and diagnostics. NanoString Technologies is an innovative company with promising products and is likely to continue playing an important role in the biotechnology industry in the future. NanoString Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.